检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:曾向阳[1] 邹小玲[1] 黄江波[2] 陈善群[1] 孙建明[1] 祖雄兵[3] 申鹏飞[3]
机构地区:[1]湖南省郴州市第一人民医院泌尿外科,湖南郴州423000 [2]南华大学附二医院泌尿外科,湖南衡阳421001 [3]中南大学湘雅医院泌尿外科,湖南长沙410008
出 处:《中国现代医学杂志》2010年第24期3819-3822,共4页China Journal of Modern Medicine
摘 要:目的探讨CXCL12/CXCR4在膀胱移行细胞癌中的表达及其与肿瘤侵袭与转移的关系。方法以免疫组织化学SABC法检测18例正常膀胱组织和70例膀胱移行细胞癌组织中CXCL12/CXCR4蛋白的表达,分析其与肿瘤分期、分级及复发的关系并探讨二者表达的相关性。结果 18例正常膀胱组织CXCL12及CXCR4阳性表达各1例,70例膀胱移行细胞癌组织中CXCL12及CXCR4阳性表达各有52例及56例;差异均有显著性(P<0.01)。CXCL12及CXCR4的阳性表达与肿瘤临床分期及复发密切相关(P<0.01),而未发现与肿瘤的病理分级有相关性(P>0.05)。CXCL12与CXCR4二者之间的表达具有明显相关性(P<0.000)。结论 CXCL12/CXCR4的表达上调可能在膀胱移行细胞癌的复发及侵袭转移过程中有重要作用。【Objective】To discuss the expression of CXCL12/CXCR4 and the relationship between tumour's invasion or metastasis and it's expression in bladder transitional cell carcinoma(BTCC).【Methods】The expression of CXCL12/CXCR4 were tested in 18 cases of normal bladder tissues and 70 cases of BTCC tissues by immunohistochemistry technology.The relationship between the CXCL12 or CXCR4 expression and pathological grade,clinical stage or recurrence was analyzed.The correlation between the expression of CXCL12 and CXCR4's was analyzed also.【Results】The over-expression of CXCL12/CXCR4 was detected in 52/56 tissues of 70 BTCC cases,whereas only 1/1 of 18 cases in normal bladder.The expression was significantly higher in BTCC than in normal bladder tissues(P〈0.01).Furthermore,the expression of CXCL12/CXCR4 was associated with the clinical stage and recurrence significantly(P〈0.05),but it was not found the association with the pathological grade(P〈0.05).There was a significantly correlation between the expression of CXCL12 and CXCR4's(P〈0.000).【Conclusion】CXCL12/CXCR4 were frequently expressed in BTCC.The over-expression of CXCL12/CXCR4 may play a critical role in the invasion and metastasis of BTCC.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.218.213.153